Legal & General Group PLC Amarin Corp Plcuk Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $203,721 - $267,762	-50,426 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $211,065 - $364,728	44,156 Added 704.24%	50,426 $349,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $49,068 - $84,902	3,520 Added 128.0%	6,270 $134,000
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $44,742 - $56,402	2,750 New	2,750 $53,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $181M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.